Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Andrea Magni"'
Autor:
Andrea Magni
Create modern yet effective multi-platform applications by building interactive UIs following a single codebase approach to boost productivityKey FeaturesDelve into the FireMonkey framework and explore its powerful capabilitiesEnhance the user experi
Publikováno v:
Scopus-Elsevier
Bowel obstruction is a common and distressing outcome in patients with abdominal or pelvic cancer. Although surgery should be the primary treatment for malignant obstruction, it is now recognized that some patients with advanced disease or in general
Autor:
G. De Palo, Tiziana Campa, Andrea Magni, Mario Clerici, Aurora Costa, Umberto Veronesi, G. Mascotti, M G Di Mauro, Franca Formelli, Daniele Moglia
Publikováno v:
Journal of Clinical Oncology. 11:2036-2042
PURPOSE Monitoring of fenretinide (4HPR) levels, kinetics, and effects on retinal was performed in patients who participated in a phase I trial and who continued to be treated for 5 years as phase III trial patients. Accumulation of 4HPR in the breas
Autor:
Maria Luisa Villa, G. De Palo, E. Clerici, Andrea Magni, E. Ferrario, Daria Trabattoni, Franca Formelli, Umberto Veronesi
Publikováno v:
British Journal of Cancer
N-(4-hydroxyphenyl) retinamide (4-HPR) is a synthetic retinoid which reduces the incidence of experimental tumours in animals and has been chosen for its weak toxicity to be tested as a chemopreventive agent in humans. The mechanism of antineoplastic
Autor:
Stefano Ciatto, Claudio Andreoli, Anna Cirillo, Rita Bonardi, Simonetta Bianchi, Giuseppe Santoro, Gabriel Farante, Andrea Magni, Tiziana Campa, Alberto Costa, Franco Berrino
Publikováno v:
Tumori Journal. 77:41-43
The risk of developing breast cancer was investigated in 339 patients in whom histologically confirmed intraductal papilloma had been surgically removed. Follow-up ranged from 2 to 14 years, (average, 6.62 years). Ten breast cancers were observed, wh
Autor:
Marjorie Perloff, Antonio Filiberti, G. De Palo, Franca Formelli, Umberto Veronesi, G.M. Danesini, A. Crippa, Ettore Marubini, Winfred F. Malone, Luigi Mariani, Nicole Rotmensz, Andrea Magni, M. Gallazzi, Tiziana Campa, Aurora Costa, Maria Antonietta Pizzichetta, A. Guzzon, M. Palvarini, M. Delle Grottaglie, M G Di Mauro
Publikováno v:
European journal of cancer (Oxford, England : 1990). 27(9)
A group of 53 patients initially participating in a phase I trial with the synthetic retinoid fenretinide was assessed for the long-term tolerability of this compound. The patients were evaluated after 42 months of drug intake at a dose of 200 mg/day
Autor:
Emanuela Dei Bei, Alberto Luini, Viviana Galimberti, Virgilio Sacchini, Franco Rilke, Umberto Veronesi, Vittorio Quagliuolo, Andrea Magni, Tiziana Campa, M. Merson, Marco Greco
Publikováno v:
Cancer. 59:682-687
Five hundred and thirty-nine patients with carcinoma of the breast treated with total axillary dissection and with positive axillary nodes were evaluated. The total number of lymph nodes removed was 11,082, with an average of 20.5 nodes per patient.
Autor:
Tiziana Campa, Antonio Filiberti, Alberto Costa, Giovanni Dossena, Maria Antonietta Pizzichetta, Andrea Magni, Marcello Tamburini, Fiamma Buranelli, C. Andreoli, Vittorio Ventafridda
Publikováno v:
Tumori Journal. 74:353-356
One hundred and one patients participating in a phase I study with the synthetic retinoid 4-HPR (4-hydroxyphenyl retinamide) were evaluated. The study was set up by Veronesi et al. during 1986 at the National Cancer Institute of Milan. The patients w
Autor:
Tiziana Campa, Marcella Del Vecchio, Franca Formelli, Fiamma Buranelli, C. Andreoli, Maria Antonietta Pizzichetta, Alberto Costa, Marjorie Perloff, Winfred F. Malone, Angelo Barbieri, Andrea Magni, Giovanni Dossena
Publikováno v:
European Journal of Cancer and Clinical Oncology. 25:805-808
Fenretinide®, N-(4-hydroxyphenyl)retinamide (HPR), is a synthetic retinoid which has been proven effective in inducing cell differentiation and in inhibiting carcinogen induced mammary tumors in rodents. Because of its efficacy and low toxicity in a